HOME >> MEDICINE >> NEWS
Queensland to be hub of Australasian kidney network

The growing problem of kidney disease will be tackled head on with the formation of a new Queensland-based research network.

To be co-ordinated through The University of Queensland's Queensland Clinical Trials Centre at the Princess Alexandra Hospital, the $1.29 million Australasian Kidney Trials Network (AKTN) will aim to improve the health and quality of life of people suffering from kidney disease.

Associate Professor Carmel Hawley, Chair of the Brisbane-based Operations Secretariat of the Network, said the AKTN would draw together leading researchers in kidney disease from around Australia and New Zealand.

"Kidney disease is one biggest health issues facing Australia at the moment along with heart disease and diabetes," Dr Hawley said.

"It affect one in seven Australian adults and there are 1.7 million people with moderate to severe chronic kidney disease.

"This Network will be focused on new and innovative clinical research to provide better treatments and outcomes for patients.

"We already have 10 trials submitted to the network researching varying treatments for chronic kidney diseases such as dialysis and transplants."

Dr Hawley said kidney disease affected one in seven Australian adults, with 1.7 million people with moderate to severe chronic kidney disease.

Other UQ researchers involved in the Network include Elaine Beller from the School of Population Health and Professors David Johnson and Wendy Hoy from the School of Medicine.

Dr Hawley said this focus on treatment and prevention trials was unique in Australia and would be a new approach to the varying renal diseases.

"The Network will be at the forefront of knowledge creation and address complex economic, technological and social needs relating to the patient care and the translation of research into clinical practice," she said.

The AKTN is the recipient of an National Health and Medical Research Council
'"/>

Contact: Associate Professor Carmel Hawley
61-732-405-080
Research Australia
14-Jul-2005


Page: 1 2

Related medicine news :

1. University of Queensland and Harvard Medical International to nourish the health workforce
2. 1 of 2 pediatric kidney disease research centers in world established
3. Indiana University Imaging Center receives $6M grant for kidney research
4. Obesity linked to hyperparathyroidism in chronic kidney disease
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
7. Quality versus quantity -- transforming kidney transplant policy
8. ACE inhibitors help preserve kidney function in IgA nephropathy
9. Treatment of kidney condition requires an individualized approach
10. Study evaluates why blacks do not successfully donate kidneys
11. Cause of gender differences in blood pressure, kidney damage under study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab ... to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. ... City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... targets, they rely on contracted partners to help with process innovation in drug ... combined drug formulation experience along with state-of-the-art analytical equipment in support of their ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology:
Cached News: